BYSI
USDBeyondSpring Inc. Ordinary Shares
$2.250-0.050 (-2.174%)
Real-time Price
Healthcare
Biotechnology
United States
Price Chart
Loading Chart...
Key Metrics
Market Metrics
Open
$2.300
High
$2.310
Low
$2.250
Volume
0.01M
Company Fundamentals
Market Cap
90.7M
Industry
Biotechnology
Country
United States
Trading Stats
Avg Volume
0.06M
Exchange
NCM
Currency
USD
52-Week Range
Low $0.98Current $2.250High $3.44
Related News
GlobeNewswire
BeyondSpring Publishes Human Clinical Study in Med (Cell Press) Showing Plinabulin-Driven Dendritic Cell Maturation and Tumor Response After Prior Checkpoint Inhibitor Failure
In eight tumors where patients failed immune checkpoint inhibitor (ICI) treatment, Plinabulin + radiation + PD-1 inhibitors demonstrated an overall response rate (ORR) of 23% and a disease control rate (DCR) of 54% in
View more
Related Stocks
Stay Updated
Set price alerts, get AI analysis updates and real-time market news.